Elizabeth A Woolf

Title: The Innovations of Elizabeth A Woolf

Introduction

Elizabeth A Woolf is a notable inventor based in Georgetown, MA (US). She has made significant contributions to the field of biotechnology, particularly in the area of G-protein coupled receptors. Her work has implications for various medical applications, including drug development and treatment of disorders.

Latest Patents

Elizabeth A Woolf holds a patent for "Isolated DNA encoding a novel human G-protein coupled receptor." This invention relates to the discovery, identification, and characterization of nucleic acids that encode a novel G protein coupled receptor (I5E) protein. The patent encompasses I5E nucleotides, host cell expression systems, I5E proteins, fusion proteins, polypeptides and peptides, antibodies to the receptor, transgenic animals that express an I5E transgene, and recombinant knock-out animals that do not express the I5E. Additionally, it includes antagonists and agonists of the receptor, as well as other compounds that modulate I5E gene expression or activity, which can be used for diagnosis, drug screening, clinical trial monitoring, and treatment of disorders such as inflammatory, central nervous system, or gastrointestinal disorders.

Career Highlights

Elizabeth A Woolf has been associated with Millennium Pharmaceuticals Limited, where she has contributed her expertise in biotechnology and molecular biology. Her innovative work has positioned her as a key figure in the development of therapeutic solutions.

Collaborations

Some of her notable coworkers include Karen J Moore and Deborah Lynn Nagle, who have collaborated with her on various projects within the field.

Conclusion

Elizabeth A Woolf's contributions to the field of biotechnology through her patent and work at Millennium Pharmaceuticals Limited highlight her role as an influential inventor. Her research continues to pave the way for advancements in medical treatments and drug development.